Accessibility Statement Skip Navigation
  • Why PRWeb
  • How It Works
  • Who Uses It
  • Pricing
  • Login
  • GDPR
  • Create a Free Account
Return to PRWeb homepage
  • News
  • Resources
  • Contact
When typing in this field, a list of search results will appear and be automatically updated as you type.

Searching for your content...

No results found. Please change your search terms and try again.
  • News in Focus
      • Browse News Releases

      • All News Releases
      • Multimedia Gallery

      • All Multimedia
      • All Photos
      • All Videos
  • Business & Money
      • Auto & Transportation

      • Aerospace, Defense
      • Air Freight
      • Airlines & Aviation
      • Automotive
      • Maritime & Shipbuilding
      • Railroads and Intermodal Transportation
      • Supply Chain/Logistics
      • Transportation, Trucking & Railroad
      • Travel
      • Trucking and Road Transportation
      • View All Auto & Transportation

      • Business Technology

      • Blockchain
      • Broadcast Tech
      • Computer & Electronics
      • Computer Hardware
      • Computer Software
      • Data Analytics
      • Electronic Commerce
      • Electronic Components
      • Electronic Design Automation
      • Financial Technology
      • High Tech Security
      • Internet Technology
      • Nanotechnology
      • Networks
      • Peripherals
      • Semiconductors
      • View All Business Technology

      • Entertain­ment & Media

      • Advertising
      • Art
      • Books
      • Entertainment
      • Film and Motion Picture
      • Magazines
      • Music
      • Publishing & Information Services
      • Radio & Podcast
      • Television
      • View All Entertain­ment & Media

      • Financial Services & Investing

      • Accounting News & Issues
      • Acquisitions, Mergers and Takeovers
      • Banking & Financial Services
      • Bankruptcy
      • Bond & Stock Ratings
      • Conference Call Announcements
      • Contracts
      • Cryptocurrency
      • Dividends
      • Earnings
      • Earnings Forecasts & Projections
      • Financing Agreements
      • Insurance
      • Investments Opinions
      • Joint Ventures
      • Mutual Funds
      • Private Placement
      • Real Estate
      • Restructuring & Recapitalization
      • Sales Reports
      • Shareholder Activism
      • Shareholder Meetings
      • Stock Offering
      • Stock Split
      • Venture Capital
      • View All Financial Services & Investing

      • General Business

      • Awards
      • Commercial Real Estate
      • Corporate Expansion
      • Earnings
      • Environmental, Social and Governance (ESG)
      • Human Resource & Workforce Management
      • Licensing
      • New Products & Services
      • Obituaries
      • Outsourcing Businesses
      • Overseas Real Estate (non-US)
      • Personnel Announcements
      • Real Estate Transactions
      • Residential Real Estate
      • Small Business Services
      • Socially Responsible Investing
      • Surveys, Polls and Research
      • Trade Show News
      • View All General Business

  • Science & Tech
      • Consumer Technology

      • Artificial Intelligence
      • Blockchain
      • Cloud Computing/Internet of Things
      • Computer Electronics
      • Computer Hardware
      • Computer Software
      • Consumer Electronics
      • Cryptocurrency
      • Data Analytics
      • Electronic Commerce
      • Electronic Gaming
      • Financial Technology
      • Mobile Entertainment
      • Multimedia & Internet
      • Peripherals
      • Social Media
      • STEM (Science, Tech, Engineering, Math)
      • Supply Chain/Logistics
      • Wireless Communications
      • View All Consumer Technology

      • Energy & Natural Resources

      • Alternative Energies
      • Chemical
      • Electrical Utilities
      • Gas
      • General Manufacturing
      • Mining
      • Mining & Metals
      • Oil & Energy
      • Oil and Gas Discoveries
      • Utilities
      • Water Utilities
      • View All Energy & Natural Resources

      • Environ­ment

      • Conservation & Recycling
      • Environmental Issues
      • Environmental Policy
      • Environmental Products & Services
      • Green Technology
      • Natural Disasters
      • View All Environ­ment

      • Heavy Industry & Manufacturing

      • Aerospace & Defense
      • Agriculture
      • Chemical
      • Construction & Building
      • General Manufacturing
      • HVAC (Heating, Ventilation and Air-Conditioning)
      • Machinery
      • Machine Tools, Metalworking and Metallurgy
      • Mining
      • Mining & Metals
      • Paper, Forest Products & Containers
      • Precious Metals
      • Textiles
      • Tobacco
      • View All Heavy Industry & Manufacturing

      • Telecomm­unications

      • Carriers and Services
      • Mobile Entertainment
      • Networks
      • Peripherals
      • Telecommunications Equipment
      • Telecommunications Industry
      • VoIP (Voice over Internet Protocol)
      • Wireless Communications
      • View All Telecomm­unications

  • Lifestyle & Health
      • Consumer Products & Retail

      • Animals & Pets
      • Beers, Wines and Spirits
      • Beverages
      • Bridal Services
      • Cannabis
      • Cosmetics and Personal Care
      • Fashion
      • Food & Beverages
      • Furniture and Furnishings
      • Home Improvement
      • Household, Consumer & Cosmetics
      • Household Products
      • Jewelry
      • Non-Alcoholic Beverages
      • Office Products
      • Organic Food
      • Product Recalls
      • Restaurants
      • Retail
      • Supermarkets
      • Toys
      • View All Consumer Products & Retail

      • Entertain­ment & Media

      • Advertising
      • Art
      • Books
      • Entertainment
      • Film and Motion Picture
      • Magazines
      • Music
      • Publishing & Information Services
      • Radio & Podcast
      • Television
      • View All Entertain­ment & Media

      • Health

      • Biometrics
      • Biotechnology
      • Clinical Trials & Medical Discoveries
      • Dentistry
      • FDA Approval
      • Fitness/Wellness
      • Health Care & Hospitals
      • Health Insurance
      • Infection Control
      • International Medical Approval
      • Medical Equipment
      • Medical Pharmaceuticals
      • Mental Health
      • Pharmaceuticals
      • Supplementary Medicine
      • View All Health

      • Sports

      • General Sports
      • Outdoors, Camping & Hiking
      • Sporting Events
      • Sports Equipment & Accessories
      • View All Sports

      • Travel

      • Amusement Parks and Tourist Attractions
      • Gambling & Casinos
      • Hotels and Resorts
      • Leisure & Tourism
      • Outdoors, Camping & Hiking
      • Passenger Aviation
      • Travel Industry
      • View All Travel

  • Policy & Public Interest
      • Policy & Public Interest

      • Advocacy Group Opinion
      • Animal Welfare
      • Congressional & Presidential Campaigns
      • Corporate Social Responsibility
      • Domestic Policy
      • Economic News, Trends, Analysis
      • Education
      • Environmental
      • European Government
      • FDA Approval
      • Federal and State Legislation
      • Federal Executive Branch & Agency
      • Foreign Policy & International Affairs
      • Homeland Security
      • Labor & Union
      • Legal Issues
      • Natural Disasters
      • Not For Profit
      • Patent Law
      • Public Safety
      • Trade Policy
      • U.S. State Policy
      • View All Policy & Public Interest

  • People & Culture
      • People & Culture

      • Aboriginal, First Nations & Native American
      • African American
      • Asian American
      • Children
      • Diversity, Equity & Inclusion
      • Hispanic
      • Lesbian, Gay & Bisexual
      • Men's Interest
      • People with Disabilities
      • Religion
      • Senior Citizens
      • Veterans
      • Women
      • View All People & Culture

  • Hamburger menu
  • Cision PRWeb provides efficient communication tools to continuously engage with target audiences across multiple online channels
  • Create a Free Account
    • ALL CONTACT INFO
    • Contact Us


      11AM ET Sunday – 8PM ET Friday

  • Send a Release
  • Sign up
  • Log in
  • Resources
  • RSS
  • GDPR
  • News in Focus
    • Browse All News
    • Multimedia Gallery
  • Business & Money
    • Auto & Transportation
    • Business Technology
    • Entertain­ment & Media
    • Financial Services & Investing
    • General Business
  • Science & Tech
    • Consumer Technology
    • Energy & Natural Resources
    • Environ­ment
    • Heavy Industry & Manufacturing
    • Telecomm­unications
  • Lifestyle & Health
    • Consumer Products & Retail
    • Entertain­ment & Media
    • Health
    • Sports
    • Travel
  • Policy & Public Interest
  • People & Culture
    • People & Culture
  • Send a Release
  • Sign up
  • Log in
  • Resources
  • RSS
  • GDPR
  • Send a Release
  • Sign up
  • Log in
  • Resources
  • RSS
  • GDPR
  • Send a Release
  • Sign up
  • Log in
  • Resources
  • RSS
  • GDPR

Do Low-T Treatments Increase Men’s Risk of Hair Loss?
  • USA - English


News provided by

Bauman Medical Group

Dec 12, 2015, 03:00 ET

Share this article

Share toX

Share this article

Share toX

Dr. Alan J. Bauman
Dr. Alan J. Bauman

Boca Raton, Florida (PRWEB) December 12, 2015 -- Low testosterone, or low-T, is a big buzzword these days among aging men - but before undergoing hormone replacement therapy (HRT), one leading medical expert urges them to be evaluated for a possible increased risk of hair loss.

"There are a wide array of preventive treatments available that can ensure men will have the best chance at maintaining a healthy head of hair throughout the course of low-T treatment, even if they are more genetically predisposed to hair loss.”

Post this

HRT is an exciting field that offers both male and female patients the opportunity to feel more youthful, healthy, energetic and sexually active as they age. In recent years, the demand among men has increased considerably for HRT, specifically as a treatment for low testosterone levels. Researchers have found that one-quarter of all men may suffer from low-T, which can leave millions of aging men with low libido, erectile dysfunction, lethargy, depression, bone weakening and other health issues.

While androgen replacement therapy using testosterone--the treatment for low-T--is effective at reversing this condition, it may put men, and even some women, at a higher risk for another unwanted sign of aging: accelerated hereditary hair loss. In the body, testosterone is naturally converted into dihydrotestosterone (DHT), the well known primary trigger for hereditary pattern hair loss.

Alan J. Bauman, M.D., a leading international hair restoration physician and researcher, will lecture on the potential connection between low-T androgen replacement therapy and male pattern hair loss on December 13th at the American Academy of Anti-Aging Medicine’s 23rd annual conference in Las Vegas. His talk, entitled “Hair Loss and Hormone Replacement: Stratagems for Managing Androgenetic Alopecia in the Presence of Androgen Replacement,” will be focused on how androgen replacement therapy may trigger, or speed up hair loss in patients who are androgen sensitive and offer guidelines for patients, age-management physicians and others who prescribe HRT.

Not all men may be concerned about hair loss, but for those that are, it’s important that they address the issue before accelerated hair loss occurs.

Three Steps for Preventing Hair Loss During Low-T Therapy

• Risk Assessment - Family history, signs of hair loss, dermoscopy, and genetic testing are some of the indicators used to determine one’s hair loss risk. New diagnostic tools and monitoring methods, such as trichometry measurements (HairCheck®), and scalp microscopic photos, are also used during a risk assessment prior to treating patients with androgen replacement.
• Treatment Options – Finateride, dutasteride, and nutraceuticals can be used to block the effects of androgen. There are also many preventative treatment options available for patients, such as minoxidil, bimatoprost, laser therapy, and PRP (platelet rich plasma). For patients looking for permanent results, hair transplantation through no scalpel/no-stitch harvesting with NeoGraft FUE or the ARTAS robotic-assisted hair transplantation technique can provide natural-looking, permanent results.
• Tracking and Follow-Up – As with any medical treatment, progress should be monitored to ensure optimal results. Hair growth can be tracked through cross-section bundle trichometry and hair caliber and density measurements, if patient isn’t achieving optimal results, treatment regimen can be adjusted accordingly.

While some male patients may have a higher risk for hair loss, Dr. Bauman urges them not to be dissuaded from undergoing low-T therapy and those being treated not to discontinue therapy until they've talked to a hair restoration specialist. “Low-T therapy has a variety of very positive health benefits for male patients, so men shouldn’t let this potential side-effect discourage them from seeking or continuing treatment,” Dr. Bauman said. “Instead, I would encourage all patients and the healthcare providers offering HRT to be aware of the potential side-effect and take the appropriate steps ahead of time to prevent it. There are a wide array of preventive treatments available that can ensure men will have the best chance at maintaining a healthy head of hair throughout the course of low-T treatment, even if they are more genetically predisposed to hair loss.”

New England Research Institute suggests that by 2025 as many as 6.5 million men in the U.S. between 30 and 79 could be suffering from low-T. With the number of men afflicted steadily increasing, it is more important than ever for anti-aging doctors and age-management practitioners to understand the risks of hair loss, be familiar with treatment stratagems and collaborate with hair restoration specialists if need be.

Today, there are many effective preventative treatments available for men undergoing hormone replacement therapy that includes testosterone, including nutraceuticals, topical medications, oral medications, low level laser therapy, Platelet Rich Plasma (PRP), FUE hair transplantation. There are also new diagnostic tools and monitoring methods that can help identify and assess a patient’s risk for hair loss, which include genetic tests, trichometry measurements (HairCheck®), and scalp microscopic photos.

The bottom line is, while certain hormone therapy may put men at an increased risk of hair loss, if proper preventative measures are started early, a significant amount of hair loss can be avoided.

For patients or doctors who are interested in learning more about Dr. Bauman, and Bauman Medical Group, or to make an appointment, visit http://www.baumanmedical.com or call 1-877-BAUMAN-9 or 561-394-0024. For those interested in learning more about the medical management of hair loss, and how to identify those at risk, Dr. Bauman offers a 3-day Healthy Hair Workshop, visit http://www.healthyhairworkshop.com.

About Dr. Alan J. Bauman:
Alan J. Bauman, M.D. is a full-time hair transplant surgeon who has treated over 17,000 patients and performed over 7,000 hair transplant procedures since starting his hair loss practice, Bauman Medical Group, in 1997 located in Boca Raton, FL.

Dr. Bauman received his M.D. degree from New York Medical College and surgical residency training at Mt. Sinai Medical Center and Beth Israel Medical Center in New York. Dr. Bauman is one of approximately 100 physicians worldwide to achieve board certification from the esteemed American and International Board of Hair Restoration Surgery. He is a Fellow of the International Society of Hair Restoration Surgery, and is an active participant and lecturer at numerous Annual Scientific Meetings and Live Surgery Workshops.

Dr. Bauman is an author of textbook chapters on the science of hair care and hair transplantation, including eyelash transplant surgery, and has been extensively featured in the world’s leading media as a medical expert and successful early-adopter of some of the most advanced technologies in the treatment of hair loss such as laser therapy and NeoGraft FUE hair transplantation.

Dr. Alan Bauman has appeared in print, radio and television as a medical expert and successful early-adopter of the most advanced technologies in the treatment of hair loss. Appearances, interviews and profiles include the Today Show, The Early Show, Good Morning America, Extra, Access Hollywood and Dateline NBC among other TV appearances. Newspaper and Magazine articles and feature stories include The New York Times, Newsweek, Cosmo, Vogue, Allure, O – The Oprah Magazine and Men’s Health among others.

About the American Academy of Anti-Aging Medicine:
As a federally registered 501(c)3 non-profit organization, the American Academy of Anti-Aging Medicine (A4M) is the world's largest non-profit scientific society of physicians and scientists dedicated to the advancement of technology to detect, prevent, and treat aging related disease and to promote research into methods to retard and optimize the human aging process.

A4M offers exclusive membership to all medical professionals where they gain access to over two-decades of established medical expertise. We are also dedicated to educating physician and scientists and are proud to be in our 23rd year of providing first-class continuing education conferences on anti-aging, regenerative and functional medicine. To further demonstrate our commitment to the future of medicine, the shared responsibility for patient outcomes and transforming health education through innovation, we offer Board Certification and numerous educational programs and events offered throughout the year.

Janet Shoup, Bauman Medical Group, +1 (828) 424-0983, [email protected]

Modal title

Contact PRWeb

  • 11AM ET Sunday – 8PM ET Friday
  • Contact Us

About PRWeb

  • About PRWeb
  • Partners
  • Partnership Programs
  • Editorial Guidelines
  • Resources

Why PRWeb

  • Why PRWeb
  • How It Works
  • Who Uses It
  • Pricing

Accounts

  • Create a Free Account
  • Log in
  • Contact Us

Do not sell or share my personal information:

  • Submit via [email protected] 
  • Call Privacy toll-free: 877-297-8921

Contact Cision

Products

About

My Services
  • All News Releases
  • Online Member Center
  • ProfNet
Cision Distribution Helpline
888-776-0942
  • Legal
  • Site Map
  • RSS
  • Cookie Settings
Copyright © 2025 Cision US Inc.